April 13 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Monday, with futures FFIc1 down 0.5%.
* GSK: GSK's GSK.L experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research told reporters.
* RIO TINTO: Rio Tinto's RIO.AX, RIO.L U.S. assets that produce the critical mineral boron have drawn interest from over a dozen potential bidders and could be valued as much as $2 billion, Bloomberg News reported, citing sources.
* LLOYDS: Lloyds Banking Group LLOY.L will not launch a legal challenge against the UK financial regulator's 9.1 billion pound compensation scheme, the Financial Times reported.
* EDINBURGH WORLDWIDE: Edinburgh Worldwide Investment Trust EWI.L said its proposed tender offer for up to 100% of its shares was rejected by investors and it would implement alternative offers recommended by Boaz Weinstein's Saba Capital.
* BUSINESS CONFIDENCE: Confidence across Britain's biggest companies slumped to its lowest since the start of the COVID-19 pandemic, a survey showed.
* OIL: Oil prices climbed above $100 a barrel as the U.S. Navy prepared to block ships to and from Iran via the Strait of Hormuz.
* METALS: Aluminium prices were range-bound as investors weighed revived concerns over inflation and a global economic recession following the collapse of the U.S.-Iran peace talks.
* GOLD: Gold prices touched a near one-week low, pressured by a stronger dollar. A surge in oil prices following failed U.S.-Iran peace talks fuelled inflation worries and dampened expectations for Federal Reserve interest rate cuts this year.
* UK'S FTSE 100: The main UK stock indexes recorded weekly gains on Friday after an agreement between the U.S. and Iran on a two-week ceasefire sent global stocks surging.
* UK CORPORATE DIARY:
Wise
WISEa.L
Q4 trading update
Heathrow
March traffic
* For more on the factors affecting European stocks, please click on: LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB
(Compiled by Neeshita Beura in Bengaluru)
((Neeshita.Beura@thomsonreuters.com))